Proteomics

Dataset Information

0

Bidirectional Control of Coronary Vascular Resistance by Eicosanoids via a Novel GPCR


ABSTRACT: Arachidonic acid metabolites epoxyeicosatrienoates (EETs) and hydroxyeicosatetraenoates (HETEs) are important regulators of myocardial blood flow and coronary vascular resistance (CVR), but their mechanisms of action are not fully understood. We identified G protein-coupled receptor 39 (GPR39) as a microvascular smooth muscle cell (mVSMC) receptor antagonistically regulated by two endogenous eicosanoids: 15-HETE, which stimulates GPR39 to increase mVSMC intracellular calcium and augment microvascular CVR, and 14,15-EET, which inhibits these actions. Furthermore, zinc ion acts as an allosteric modulator of GPR39 to potentiate the efficacy of the two ligands. The study elucidates the roles of eicosanoids in cardiovascular physiology and disease and provide an opportunity for the development of novel GPR39-targeting therapies for cardiovascular disease.

INSTRUMENT(S): LTQ, LTQ Velos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart, Smooth Muscle Cell

DISEASE(S): Cardiovascular System Disease

SUBMITTER: Phillip Wilmarth  

LAB HEAD: Nabil J. Alkayed

PROVIDER: PXD013952 | Pride | 2022-04-13

REPOSITORIES: Pride

altmetric image

Publications


Arachidonic acid metabolites epoxyeicosatrienoates (EETs) and hydroxyeicosatetraenoates (HETEs) are important regulators of myocardial blood flow and coronary vascular resistance (CVR), but their mechanisms of action are not fully understood. We applied a chemoproteomics strategy using a clickable photoaffinity probe to identify G protein-coupled receptor 39 (GPR39) as a microvascular smooth muscle cell (mVSMC) receptor selective for two endogenous eicosanoids, 15-HETE and 14,15-EET, which act o  ...[more]

Similar Datasets

2024-09-11 | PXD053165 | Pride
2010-08-03 | E-GEOD-12384 | biostudies-arrayexpress
2010-08-03 | E-GEOD-12385 | biostudies-arrayexpress
2023-03-02 | PXD039931 | Pride
2023-11-29 | PXD045712 | Pride
2024-10-28 | PXD048326 | Pride
2020-03-09 | PXD017539 | Pride
2022-08-29 | PXD036349 | Pride
2024-01-02 | PXD047413 | Pride
2023-10-09 | PXD042220 | Pride